Skip to main content
. 2023 Apr 17;11(4):e006334. doi: 10.1136/jitc-2022-006334

Figure 1.

Figure 1

Sequencing, clinical information and the mutation spectrum of the tumor tissues of 14 patients with HCC. (A) Illustration of WES and RNA sequencing performed on each sample from 14 patients with HCC. (B) Clinical characteristics of 14 patients with HCC. (C) The proportions of base substitution subtypes in samples. (D) The proportions of mutational signatures in samples. (E) The key mutated genes and the TMB in samples. HCC, hepatocellular carcinoma; PBMC, peripheral blood mononuclear cell; PVTT, portal vein tumor thrombus; TMB, tumor mutation burden; WES, whole-exome sequencing.